Brief: Gland Pharma Q3 Consol Net Profit 2.61 Billion Rupees vs IBES Est. 2.44 Billion Rupees
28/01/2026 11:42
Jan 28 (Reuters) - Gland Pharma Ltd GLAD.NS: Q3 CONSOL NET PROFIT 2.61 BILLION RUPEES; IBES EST. 2.44 BILLION RUPEES Q3 CONSOL REVENUE FROM OPERATIONS 16.95 BILLION RUPEES; IBES EST. 15.87 BILLION RUPEES Further company coverage: GLAD.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant